Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Completed · Phase 2
Conditions studied: Esophageal Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with or without radiation therapy in treating patients who have esophageal cancer.
Key facts
- Study ID
- NCT00021320
- Run by
- Fox Chase Cancer Center
- People needed
- 21
- Starts
- 2000-05-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2014-05-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.